CStone Pharmaceuticals — Director's Dealing 2022

Jul 5, 2022

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

5 July 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party	Date	Descriptionof relevantsecurities	Descriptionof products	Nature ofdealings	Number ofreferencesecurities towhich thederivativesrelate	Maturitydate /closing outdate	Referenceprice	Total amountpaid / received	Resultantbalance(includingthose of anyperson withwhom there isan agreementorunderstanding)
ChinaInternationalCapitalCorporationLimited	4 July 2022	Derivatives	Other types ofproducts	Closing out of aderivative contract	44,000	19 February2025	$23.5312	$1,034,500.0060	26,000
		Derivatives	Other types ofproducts	Closing out of aderivative contract	24,000	22 May2024	$23.5267	$564,300.0000	28,000
		Derivatives	Other types ofproducts	Closing out of aderivative contract	44,000	19 February2025	$23.5312	$1,034,500.0060	26,000

==> picture [71 x 43] intentionally omitted <==

Public Disclosure Form

			Derivatives	Other types ofproducts	Closing out of aderivative contract	24,000	22 May2024	$23.5267	$564,300.0000	28,000

End

Note:

China International Capital Corporation Limited is an exempt principal trader connected with the Offeror. Dealings were made for its own account.